Skip to main content
Livermore
Livermore
ZHEN

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings

Shares (Q2 2026)
964
Value
$290.5K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ALNY by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026964$290.5K<0.1%+73+8.2%AddedHolders
Q1 2026891$294.8K<0.1%+65+7.9%AddedHolders
Q4 2025826$328.5K<0.1%+30+3.8%AddedHolders
Q3 2025796$363.3K<0.1%−21−2.6%ReducedHolders
Q2 2025817$266.4K<0.1%−45−5.2%ReducedHolders
Q1 2025862$232.7K<0.1%+31+3.7%AddedHolders
Q4 2024831$195.5K<0.1%+292+54.2%AddedHolders
Q3 2024539$148.2K<0.1%+140+35.1%AddedHolders
Q2 2024399$96.9K<0.1%+156+64.2%AddedHolders
Q1 2024243$36.3K<0.1%+32+15.2%AddedHolders
Q4 2023211$40.4K<0.1%−16−7.0%ReducedHolders
Q3 2023227$40.2K<0.1%+18+8.6%AddedHolders
Q2 2023209$39.7K<0.1%+27+14.8%AddedHolders
Q1 2023182$36.5K<0.1%−12−6.2%ReducedHolders
Q4 2022194$46.1K<0.1%+9+4.9%AddedHolders
Q3 2022185$37.0K<0.1%+12+6.9%AddedHolders
Q2 2022173$25.0K<0.1%−38−18.0%ReducedHolders
Q1 2022211$35.0K<0.1%−55−20.7%ReducedHolders
Q4 2021266$45.0K<0.1%−84−24.0%ReducedHolders
Q3 2021350$66.0K<0.1%+167+91.3%AddedHolders
Q2 2021183$31.0K<0.1%−9−4.7%ReducedHolders
Q1 2021192$27.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.